CoChat

Inhibition of the glutaredoxin and thioredoxin systems and ribonucleotide reductase by mutant p53-targeting compound APR-246

Open access

The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index; 18 of the 50 sources its claims cite were checked for support.

Abstract

The tumor suppressor p53 is commonly inactivated in human tumors, allowing evasion of p53-dependent apoptosis and tumor progression. The small molecule APR-246 (PRIMA-1 Met ) can reactive mutant p53 in tumor cells and trigger cell death by apoptosis. The thioredoxin (Trx) and glutaredoxin (Grx) systems are important as antioxidants for maintaining cellular redox balance and providing electrons for thiol-dependent reactions like those catalyzed by ribonucleotide reductase and peroxiredoxins (Prxs). We show here that the Michael acceptor methylene quinuclidinone (MQ), the active form of APR-246, is a potent direct inhibitor of Trx1 and Grx1 by reacting with sulfhydryl groups in the enzymes. The inhibition of Trx1 and Grx1 by APR-246/MQ is reversible and the inhibitory efficiency is dependent on the presence of glutathione. APR-246/MQ also inhibits Trxs in mutant p53-expressing Saos-2 His-273 cells, showing modification of Trx1 and mitochondrial Trx2. Inhibition of the Trx and Grx systems leads to insufficient reducing power to deoxyribonucleotide production for DNA replication and repair and peroxiredoxin for removal of ROS. We also demonstrate that APR-246 and MQ inhibit ribonucleotide reductase (RNR) in vitro and in living cells. Our results suggest that APR-246 induces tumor cell death through both reactivations of mutant p53 and inhibition of cellular thiol-dependent redox systems, providing a novel strategy for cancer therapy.

Overview

CoChat Summary

TL;DR

APR-246’s active metabolite MQ directly and reversibly inhibits Trx1 and Grx1 by modifying thiols, and APR-246/MQ also inhibits ribonucleotide reductase (RNR) in vitro and in cells. These redox-system effects occur alongside mutant p53 reactivation and may contribute to APR-246-induced tumor cell death.

Key findings

  • Preheated APR-246 inhibited the Trx system with an IC50 of 7.15 µM and the Grx system with an IC50 of 60.0 µM; direct inhibition of Trx1 and Grx1 gave IC50 values of 5.40 µM and 57.7 µM, respectively.
  • MQ formed adducts with Trx1 and Grx1: MALDI-TOF showed mass shifts of 137 Da, with all 5 Trx1 thiols modified at 0.5 mM MQ, whereas Grx1 showed 4 adducts at 0.5 mM MQ and required 1 mM MQ for modification of all 5 thiols.
  • In Saos-2-His-273 cells treated with 65 µM APR-246 for 24 h, fully reduced Trx1 decreased from 76.3% to 17.0%, and Trx2 without free thiols increased from 17% to 45%.
  • APR-246 and MQ inhibited RNR in vitro, with MQ at 40 µM almost completely inhibiting activity; APR-246 also dose-dependently inhibited RNR in Saos-2 and Saos-2-His-273 cells at 12.5, 25, and 50 µM.

Methods

  • In vitro assays used recombinant human Trx1 and Grx1, rat TrxR, yeast GR, NADPH, GSH, and fluorescent substrates (FITC-insulin or E-GS-BSA); thiol content was measured with DTNB, and MQ adducts were analyzed by MALDI-TOF mass spectrometry.
  • Cell experiments used p53-null Saos-2 and mutant p53-expressing Saos-2-His-273 cells treated with APR-246 for 24 h, followed by redox Western blotting for Trx1/Trx2, anti-glutathione Western blotting for total glutathionylation, and RNR activity assays.
  • RNR activity was measured by conversion of [3H]CDP to [3H]dCDP in vitro and in cell lysates; data were analyzed with GraphPad Prism 5 and Quantity One software.

Limitations

  • The paper does not state a formal limitations section.
  • Evident from the text: most mechanistic evidence comes from in vitro recombinant proteins and high concentrations (e.g., 0.5–1 mM MQ for mass spectrometry), while cell data are limited to Saos-2 osteosarcoma lines with or without His-273 mutant p53, so generalizability is unclear.
  • The paper states that Trx1 activity was fully restored after long-term kinetic measurements (data not shown), indicating transient inhibition; this is stated but not shown, and no in vivo animal or clinical data are presented.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41598-018-31048-7

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Inhibition of the GSH-Grx system and Trx system by APR-246. (A) The chemical structures of APR-246 and MQ. (B) The GSH-Grx system (0.25 mM NADPH, 50 nM yeast GR, 50–500 µM GSH, 0.1 µM Grx1) was incubated with pre-heated APR-246 in a 96-well microtiter plate for 60 min. Grx1 activity was assayed by addition of 20 µM E-GS-BSA. Data are shown as mean ± SD (n = 3). (C) Inhibition of Trx system by APR-246, preheated APR-246 and MQ. After incubation of the Trx system (0.1 µM Trx1, 50 nM TrxR, and 0.25 mM NADPH) with APR246, preheated APR-246, and MQ for 60 min, 6 µM FITC-insulin was added to measure Trx activity. Results are shown as the means ± SEM of three experiments. (D) Time course of interaction of GSH with MQ. GSH (0.5 mM) was incubated with 0.25 and 0.5 mM MQ with various time points and unreacted free thiols in GSH were determined by titration with 2 mM DTNB. The reaction was shown to be a second order with a rate constant (k2) of 21.6 M−1 s−1. (E) Recombinant rat TrxR (0.5 µM) was reduced by 200 µM NADPH for 5 min and then incubated with 200 µM MQ in the absence or presence of GSH at room temperature overnight. The GSH was then removed by MicrospinTM G-25 columns and TrxR activity was measured by a DTNB reduction assay. TrxR without the treatment with MQ was used as control. Data are shown as mean ± SD (n = 2).
Figure 1 Inhibition of the GSH-Grx system and Trx system by APR-246. (A) The chemical structures of APR-246 and MQ. (B) The GSH-Grx system (0.25 mM NADPH, 50 nM yeast GR, 50–500 µM GSH, 0.1 µM Grx1) was incubated with pre-heated APR-246 in a 96-well microtiter plate for 60 min. Grx1 activity was assayed by addition of 20 µM E-GS-BSA. Data are shown as mean ± SD (n = 3). (C) Inhibition of Trx system by APR-246, preheated APR-246 and MQ. After incubation of the Trx system (0.1 µM Trx1, 50 nM TrxR, and 0.25 mM NADPH) with APR246, preheated APR-246, and MQ for 60 min, 6 µM FITC-insulin was added to measure Trx activity. Results are shown as the means ± SEM of three experiments. (D) Time course of interaction of GSH with MQ. GSH (0.5 mM) was incubated with 0.25 and 0.5 mM MQ with various time points and unreacted free thiols in GSH were determined by titration with 2 mM DTNB. The reaction was shown to be a second order with a rate constant (k2) of 21.6 M−1 s−1. (E) Recombinant rat TrxR (0.5 µM) was reduced by 200 µM NADPH for 5 min and then incubated with 200 µM MQ in the absence or presence of GSH at room temperature overnight. The GSH was then removed by MicrospinTM G-25 columns and TrxR activity was measured by a DTNB reduction assay. TrxR without the treatment with MQ was used as control. Data are shown as mean ± SD (n = 2).CC BY · PubMed Central
Figure 2 Comparison of the inhibition of the hTrx1 and hGrx1 systems with the inhibition of individual Trx1 and Grx1 by APR-246. (A) Inhibition of the Trx system by preheated APR-246. The thioredoxin system (50 nM TrxR1, 0.1 µM Trx, and 0.25 mM NADPH) was incubated with preheated APR-246 (2–20 µM) for 60 min. Trx activity was then assessed by the FITC-insulin coupled method to measure IC50 value. Results are shown as means ± SD of three experiments. (B) Inhibition of the Grx system by preheated APR-246. The GSH-Grx system (0.25 mM NADPH, 50 nM yeast GR, 50 µM GSH 0.1 µM Grx1) was incubated with pre-heated APR-246 (10–100 µM) for 60 min. Grx1 activity was then assessed by the E-GS-BSA coupled method. Results are shown as means ± SEM of three experiments. Inhibition of Trx1 (C) and Grx1 (D) by preheated APR-246. Trx1 and Grx1 were prereduced with 10 mM DTT and desalted prior to 60 min incubation. The mixtures were then added onto 96-well plates along with the remaining components of the respective systems to measure the activity as described above. Results are shown as means ± SEM of three experiments.
Figure 2 Comparison of the inhibition of the hTrx1 and hGrx1 systems with the inhibition of individual Trx1 and Grx1 by APR-246. (A) Inhibition of the Trx system by preheated APR-246. The thioredoxin system (50 nM TrxR1, 0.1 µM Trx, and 0.25 mM NADPH) was incubated with preheated APR-246 (2–20 µM) for 60 min. Trx activity was then assessed by the FITC-insulin coupled method to measure IC50 value. Results are shown as means ± SD of three experiments. (B) Inhibition of the Grx system by preheated APR-246. The GSH-Grx system (0.25 mM NADPH, 50 nM yeast GR, 50 µM GSH 0.1 µM Grx1) was incubated with pre-heated APR-246 (10–100 µM) for 60 min. Grx1 activity was then assessed by the E-GS-BSA coupled method. Results are shown as means ± SEM of three experiments. Inhibition of Trx1 (C) and Grx1 (D) by preheated APR-246. Trx1 and Grx1 were prereduced with 10 mM DTT and desalted prior to 60 min incubation. The mixtures were then added onto 96-well plates along with the remaining components of the respective systems to measure the activity as described above. Results are shown as means ± SEM of three experiments.CC BY · PubMed Central
Figure 3 Efficient inhibition of Trx1 and Grx1 by preheated APR-246 is thiol-dependent and reversible. Indicated concentrations of preheated APR-246 efficiently inhibited 20 µM fully reduced Trx1 and the inhibition was significantly reversed by incubation with (A) 50 nM TrxR or (B) 10 mM DTT. (C) Inhibition of 20 µM Grx1 is significantly reversed upon incubation with 10 mM DTT. Amount of free thiols was determined with the DTNB assay49. Results are the means ± SEM (n = 3).
Figure 3 Efficient inhibition of Trx1 and Grx1 by preheated APR-246 is thiol-dependent and reversible. Indicated concentrations of preheated APR-246 efficiently inhibited 20 µM fully reduced Trx1 and the inhibition was significantly reversed by incubation with (A) 50 nM TrxR or (B) 10 mM DTT. (C) Inhibition of 20 µM Grx1 is significantly reversed upon incubation with 10 mM DTT. Amount of free thiols was determined with the DTNB assay49. Results are the means ± SEM (n = 3).CC BY · PubMed Central
Figure 4 Effects of APR-246 on redox status of Trx1 and Trx2 in Saos-2 and Saos-2 His-273 cells. p53 null Saos-2 and mutant p53-expressing Saos-2-His-273 cells were treated with 65 µM APR-246 for 24 hours. The redox states of Trx1 (upper) and Trx2 (lower) were detected with a redox Western blotting method (two separated gels, original picture see Supplementary Fig. S2). The table shows the percentage of adjusted volume of each band for respective treatment groups.
Figure 4 Effects of APR-246 on redox status of Trx1 and Trx2 in Saos-2 and Saos-2 His-273 cells. p53 null Saos-2 and mutant p53-expressing Saos-2-His-273 cells were treated with 65 µM APR-246 for 24 hours. The redox states of Trx1 (upper) and Trx2 (lower) were detected with a redox Western blotting method (two separated gels, original picture see Supplementary Fig. S2). The table shows the percentage of adjusted volume of each band for respective treatment groups.CC BY · PubMed Central
Figure 5 Effects of preheated APR-246 on total cellular glutathionylation in Saos-2 and Saos-2 His-273 cells. After 24 hours treatment, cells were lysed and the supernatant was separated by SDS-PAGE (12%) and probed with an anti-glutathione antibody (VIROGEN Corporation). Anti-GAPDH (Santa Cruz) antibody was used as loading control.
Figure 5 Effects of preheated APR-246 on total cellular glutathionylation in Saos-2 and Saos-2 His-273 cells. After 24 hours treatment, cells were lysed and the supernatant was separated by SDS-PAGE (12%) and probed with an anti-glutathione antibody (VIROGEN Corporation). Anti-GAPDH (Santa Cruz) antibody was used as loading control.CC BY · PubMed Central
Figure 6 Effect of APR-246 and MQ on RNR activity. (A) Effects of APR-246 and MQ on RNR activity in vitro using recombinant R1 and R2 proteins. (B) RNR activity in Saos-2 cells treated with 12.5, 25 and 50 µM of APR-246 for 24 hours with addition of excess recombinant R1 and R2. (C) RNR activity in Saos-2-His273 cells treated with 12.5, 25 and 50 µM of APR-246 for 24 hours with addition of excess recombinant R1 and R2.
Figure 6 Effect of APR-246 and MQ on RNR activity. (A) Effects of APR-246 and MQ on RNR activity in vitro using recombinant R1 and R2 proteins. (B) RNR activity in Saos-2 cells treated with 12.5, 25 and 50 µM of APR-246 for 24 hours with addition of excess recombinant R1 and R2. (C) RNR activity in Saos-2-His273 cells treated with 12.5, 25 and 50 µM of APR-246 for 24 hours with addition of excess recombinant R1 and R2.CC BY · PubMed Central

Verification

Claims the paper makes

14 Valid · 1 Not valid · 19 Not checked · 56 Own results and interpretations

45 more claims · 2 with their cited sources checked

Create a free account to see all 90 claims and to verify the 5 references still open.

See all claims — free account
  • It may state two separate claims as one. 33
  • Probably not a substantial claim. 8

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 50 references

Cited by

See all 73

Metadata

Authors
Haffo, L., Lu, J., Bykov, V. J. N., Martin, S. S., Ren, X., Coppo, L., Wiman, K. G., & Holmgren, A.
Affiliations
  • Karolinska Institutet (SE)
  • Southwest University (CN)
Corresponding author
  • Wiman, Klas G.
  • Holmgren, Arne
Venue
Scientific Reports
Published
2018-08-23
Volume
8
Issue
1
Pages
12671-12671
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2887430569
Cited by
73
References
51
Citations by year
2026: 7 · 2025: 5 · 2024: 6 · 2023: 12 · 2022: 16 · 2021: 16 · 2020: 7 · 2019: 4
FWCI
2.40
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Cancerfonden
  • Karolinska Institutet
  • Vetenskapsrådet
  • Radiumhemmets Forskningsfonder
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
Keywords
APR-246, mutant p53, thioredoxin, glutaredoxin, ribonucleotide reductase, redox homeostasis, glutathione, peroxiredoxin, apoptosis, reactive oxygen species, DNA replication, cancer therapy, Saos-2 cells
MeSH terms
Antioxidants, DNA Repair, Humans, Mitochondria, Oxidation-Reduction, Quinuclidines, Ribonucleotide Reductases, Mass Spectrometry, Sulfhydryl Compounds, Thioredoxins, Blotting, Western, Reactive Oxygen Species, Cell Line, Tumor, Glutaredoxins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of the glutaredoxin and thioredoxin systems and ribonucleotide reductase by mutant p53-targeting compound APR-246. https://app.cochat.ai/papers/10.1038/s41598-018-31048-7
The paper
Haffo, L., Lu, J., Bykov, V. J. N., Martin, S. S., Ren, X., Coppo, L., Wiman, K. G., & Holmgren, A. (2018). Inhibition of the glutaredoxin and thioredoxin systems and ribonucleotide reductase by mutant p53-targeting compound APR-246. Scientific Reports. https://doi.org/10.1038/s41598-018-31048-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.